Nam Tai Property News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.12.17	Nam Tai Property Inc. Announces Date of Report of Fourth Quarter 2017 Results and Payment of Quarterly Dividend (PR Newswire)
11.12.17	NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333 (PR Newswire)
11.12.17	NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333 (PR Newswire)
11.12.17	NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333 (PR Newswire)
30.11.17	Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) (PR Newswire)
30.11.17	NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone (PR Newswire)
30.11.17	Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) (PR Newswire)
30.11.17	Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ) (PR Newswire)
30.11.17	NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone (PR Newswire)
30.11.17	NeuroVive's Genetic Mitochondrial Disease Program NVP015 Reaches Significant Milestone (PR Newswire)
15.11.17	NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference (PR Newswire)
15.11.17	NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference (PR Newswire)
15.11.17	NeuroVive Presents TBI Clinical Study Results at Nordic Neurotrauma Conference (PR Newswire)
31.10.17	NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development (PR Newswire)
31.10.17	NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development (PR Newswire)
31.10.17	NeuroVive Signs Collaboration Agreement With University of Florida for TBI Biomarker Development (PR Newswire)
30.10.17	Nam Tai Property Inc. Reports Q3 2017 Results (PR Newswire)
18.10.17	NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research (PR Newswire)
18.10.17	NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research (PR Newswire)
18.10.17	NeuroVive and Lund University Collaboration Receives Grant for Liver Cancer Research (PR Newswire)
22.09.17	Nam Tai Property Inc. Announces Director Departure (PR Newswire)
22.09.17	NAM TAI PROPERTY INC. Announces Date of Report of Third Quarter 2017 Results and Payment of Quarterly Dividend (PR Newswire)
05.09.17	$99.11 Billion Building Automation System Market to 2022 (PR Newswire)
31.07.17	Nam Tai Property Inc. Reports Q2 2017 Results (PR Newswire)
12.07.17	Nam Tai Property Inc. Announces Share Purchase by Kaisa Group (PR Newswire)
19.06.17	NAM TAI PROPERTY INC. Announces Date of Report of Second Quarter 2017 Results and Payment of Quarterly Dividend (PR Newswire)
14.06.17	NAM TAI PROPERTY INC. Property Development Projects Update (PR Newswire)
01.06.17	NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project (PR Newswire)
01.06.17	NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project (PR Newswire)
01.06.17	NeuroVive Receives Research Grant From Vinnova for Development of the NVP015 Genetic Mitochondrial Disease Project (PR Newswire)
18.05.17	NeuroVive Pharmaceutical AB Interim Report January - March 2017 (PR Newswire)
18.05.17	NeuroVive Pharmaceutical AB Interim Report January - March 2017 (PR Newswire)
02.05.17	NAM TAI PROPERTY INC. Reports Q1 2017 Results (PR Newswire)
02.05.17	NeuroVive in-licenses a Genetic Mitochondrial Disease Clinical Stage Project From Yungjin Pharm (PR Newswire)
20.04.17	NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects (PR Newswire)
20.04.17	NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects (PR Newswire)
20.04.17	NeuroVive Presents Preclinical Findings of NV556 in NASH Showing Confirmatory Anti-fibrotic Effects (PR Newswire)
20.03.17	NAM TAI PROPERTY INC. Announces Date of Report of First Quarter 2017 Results and Payment of Quarterly Dividend (PR Newswire)
13.03.17	Nam Tai Property Inc. Annual Report on Form 20-F for 2016 Filed With SEC on March 10, 2017 (PR Newswire)
13.02.17	Nam Tai Property Inc. PFIC Announcement (PR Newswire)
23.01.17	Nam Tai Property Inc. Reports Q4 2016 Results (PR Newswire)
12.12.16	Nam Tai Property Inc. Announces Date of Report of Fourth Quarter 2016 Results and Payment of Quarterly Dividend (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Nam Tai Property Inc

Aktien Top/Flop

Meistgelesene Nachrichten